Emerald Advisers, LLC Intercept Pharmaceuticals, Inc. Transaction History

Emerald Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$57.36 - $124.1 $7.34 Million - $15.9 Million	-127,927 Closed	0 $0
Q3 2019 Oct 31, 2019	SELL	$58.69 - $80.46 $1.14 Million - $1.57 Million	-19,482 Reduced 13.22%	127,927 $8.49 Million
Q2 2019 Jul 31, 2019	BUY	$77.77 - $120.68 $2.07 Million - $3.21 Million	26,589 Added 22.01%	147,409 $11.7 Million
Q1 2019 May 01, 2019	BUY	$91.83 - $120.68 $11.1 Million - $14.6 Million	120,820 New	120,820 $13.5 Million
Q1 2018 Apr 26, 2018	SELL	$52.72 - $67.25 $8.57 Million - $10.9 Million	-162,560 Closed	0 $0
Q4 2017 Feb 05, 2018	BUY	$58.2 - $72.76 $9.46 Million - $11.8 Million	162,560	162,560 $9.5 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.